Thermo Fisher Scientific Comprehensive Income Attributable to Noncontrolling Interests decreased by 112.5% to -$1.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 112.5%, from $8.00M to -$1.00M.
tmo_comprehensive_income_attributable_to_nci| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $1.00M | $2.00M | $7.00M | $0.00 | $6.00M | -$6.00M | -$26.00M | $1.00M | $3.00M | $6.00M | $8.00M | -$1.00M |
| QoQ Change | — | +0.0% | +100.0% | +250.0% | -100.0% | — | -200.0% | -333.3% | +103.8% | +200.0% | +100.0% | +33.3% | -112.5% |
| YoY Change | — | — | — | +600.0% | -100.0% | +200.0% | -185.7% | — | -83.3% | +150.0% | +123.1% | +700.0% | -112.5% |